For: | Nabi AHMN, Ebihara A, Shekhar HU. Impacts of SARS-CoV-2 on diabetes mellitus: A pre and post pandemic evaluation. World J Virol 2023; 12(3): 151-171 [PMID: 37396707 DOI: 10.5501/wjv.v12.i3.151] |
---|---|
URL: | https://www.wjgnet.com/2220-3249/full/v12/i3/151.htm |
Number | Citing Articles |
1 |
Altijana Hromić-Jahjefendić, Abas Sezer, Irma Mahmuljin. . Progress in Molecular Biology and Translational Science 2025; doi: 10.1016/bs.pmbts.2025.01.007
|
2 |
Yu Li, Guanni Li, Jiahong Li, Zirui Luo, Yaxuan Lin, Ning Lan, Xiaodan Zhang. Correlation of diabetes and adverse outcomes in hospitalized COVID-19 patients admitted to a tertiary hospital in China during a small-scale COVID-19 outbreak. PeerJ 2025; 13: e18865 doi: 10.7717/peerj.18865
|
3 |
A. Dilara Demir, Zeynep Cetin, Fikriye Milletli Sezgin. Serum FGF-21 Levels During COVID-19 Infection Recovery Period. Medical Bulletin of Haseki 2024; 62(3): 168 doi: 10.4274/haseki.galenos.2024.9752
|
4 |
Larisa Ghemiș, Ancuța Goriuc, Bogdan Minea, Gina Eosefina Botnariu, Maria-Alexandra Mârțu, Melissa Ențuc, Daniel Cioloca, Liliana Georgeta Foia. Myeloid-Derived Suppressor Cells (MDSCs) and Obesity-Induced Inflammation in Type 2 Diabetes. Diagnostics 2024; 14(21): 2453 doi: 10.3390/diagnostics14212453
|